NASDAQ:AMST Amesite (AMST) Stock Price, News & Analysis → This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad) Free AMST Stock Alerts $3.05 +0.10 (+3.39%) (As of 11:17 AM ET) Add Compare Share Share Today's Range$2.99▼$3.0550-Day Range$1.88▼$3.7752-Week Range$1.72▼$4.34Volume1,320 shsAverage Volume652,063 shsMarket Capitalization$7.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Amesite alerts: Email Address Ad Behind the MarketsThis Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!Get the name of the company and their stock ticker here >>> About Amesite Stock (NASDAQ:AMST)Amesite Inc., an artificial intelligence driven platform and course designer, that provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. It serves businesses, universities and colleges, K-12 schools, museums, and non-profit organizations. Amesite Inc. was incorporated in 2017 and is headquartered in Detroit, Michigan.Read More AMST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMST Stock News HeadlinesJune 17 at 7:30 AM | globenewswire.comAmesite Announces Contract Renewal with EWIE Group of CompaniesJune 13, 2024 | americanbankingnews.comAmesite Inc. (NASDAQ:AMST) Short Interest UpdateJune 18, 2024 | Behind the Markets (Ad)This Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!May 30, 2024 | globenewswire.comAmesite CEO Dr. Ann Marie Sastry to Be Panelist at Mackinac Policy Conference 2024May 21, 2024 | finance.yahoo.comAmesite Launches Explorer Seminars to Connect Top Faculty with Outstanding High School StudentsMay 16, 2024 | benzinga.comPioneering Education With AI-Driven EdTech Firm Amesite (NASDAQ: AMST): Insights From CEO Dr. Ann Marie SastryMay 13, 2024 | finance.yahoo.comAmesite Third Quarter 2024 Earnings: US$0.56 loss per share (vs US$0.37 loss in 3Q 2023)May 10, 2024 | markets.businessinsider.comAmesite Releases New Suite of AI Tools for Job Applications on NurseMagic™ AppJune 18, 2024 | Behind the Markets (Ad)This Weight Loss Company Can't Make Enough ProductA tiny pharmaceutical company is getting overwhelmed by a massive demand for its new weight loss marvel. They recently reported over 25,000 Americans are starting their drug each week - a 4X increase since December!May 10, 2024 | globenewswire.comAmesite Releases New Suite of AI Tools for Job Applications on NurseMagic™ AppMay 7, 2024 | globenewswire.comAmesite Announces Strategic Five-Year Partnership with Franciscan Missionaries of Our Lady University to Deliver Healthcare Training for Healthcare ProfessionalsApril 30, 2024 | finance.yahoo.comAmesite Launches AI and Technical Training Programs with Volunteer State Community CollegeApril 28, 2024 | finance.yahoo.comAmesite Inc. (AMST)April 24, 2024 | msn.comWhy Edtech Company Amesite Shares Are Skyrocketing TodayApril 24, 2024 | investorplace.comWhy Is Amesite (AMST) Stock Up 74% Today?April 24, 2024 | globenewswire.comAmesite Launches Revolutionary NurseMagic™ App in Beta to Empower 5.2 Million Nurses with AI ToolsApril 16, 2024 | msn.comHow Amesite (NASDAQ: $AMST) Is Revolutionizing Learning With Artificial IntelligenceMarch 11, 2024 | globenewswire.comAmesite Announces Strategic Five-Year Partnership to Expand Workforce Development with Joliet Junior CollegeMarch 6, 2024 | finance.yahoo.comAmesite Announces Launch of Active Shooter Preparedness App with World Renowned Expert Chris GrollnekMarch 4, 2024 | msn.comAmesite's AI Platform Powers Up Healthcare Continuing Education With PACE: DetailsMarch 4, 2024 | globenewswire.comAmesite Announces Partnership with PACE to Deliver Accredited Continuing Education for Healthcare Professionals Using Artificial Intelligence-Driven PlatformMarch 4, 2024 | globenewswire.comAmesite Announces Partnership with PACE to Deliver Accredited Continuing Education for Healthcare Professionals Using Artificial Intelligence-Driven PlatformFebruary 22, 2024 | uk.finance.yahoo.comAmesite Inc. (AMST) environment, social and governance (ESG) ratings – Yahoo FinanceFebruary 21, 2024 | benzinga.comAmesite Stock (NASDAQ:AMST) Insider TradesFebruary 17, 2024 | finance.yahoo.comAmesite Second Quarter 2024 Earnings: US$0.36 loss per share (vs US$0.28 loss in 2Q 2023)February 13, 2024 | finance.yahoo.comAmesite Announces New Article Automation Feature, Enabling Continuous Program Updates from 14,000 Academic SourcesFebruary 7, 2024 | msn.comAmesite Issues Equity to Strengthen Advisory PartnershipSee More Headlines Receive AMST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amesite and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/17/2024Next Earnings (Estimated)6/19/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:AMST CUSIPN/A CIK1807166 Webwww.amesite.com Phone734-876-8130FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,150,000.00 Net Margins-1,596.87% Pretax Margin-1,596.87% Return on Equity-86.32% Return on Assets-82.41% Debt Debt-to-Equity RatioN/A Current Ratio14.87 Quick Ratio14.87 Sales & Book Value Annual Sales$262,036.00 Price / Sales28.62 Cash FlowN/A Price / Cash FlowN/A Book Value$2.40 per share Price / Book1.23Miscellaneous Outstanding Shares2,542,000Free Float1,579,000Market Cap$7.50 million OptionableNot Optionable Beta1.46 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Ann Marie Sastry Ph.D. (Age 56)Chairperson, President & CEO Comp: $550kMs. Sherlyn W. Farrell (Age 61)Chief Financial Officer Comp: $148.2kMr. Brandon OwensVice President of SalesMs. Kalie WortingerSenior Manager of EngineeringMr. Jay Majumdar (Age 55)Vice President of Partnerships Key CompetitorsSnailNASDAQ:SNALNetSol TechnologiesNASDAQ:NTWKMMTecNASDAQ:MTCCLPS IncorporationNASDAQ:CLPSHitek GlobalNASDAQ:HKITView All CompetitorsInsidersAnn Marie SastryBought 10,000 shares on 12/20/2023Total: $18,500.00 ($1.85/share)View All Insider Transactions AMST Stock Analysis - Frequently Asked Questions How have AMST shares performed in 2024? Amesite's stock was trading at $2.25 at the beginning of the year. Since then, AMST stock has increased by 31.1% and is now trading at $2.95. View the best growth stocks for 2024 here. Are investors shorting Amesite? Amesite saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 52,800 shares, a decrease of 41.1% from the May 15th total of 89,700 shares. Based on an average trading volume of 1,160,000 shares, the short-interest ratio is presently 0.0 days. Approximately 3.1% of the shares of the company are sold short. View Amesite's Short Interest. When is Amesite's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 19th 2024. View our AMST earnings forecast. When did Amesite IPO? Amesite (AMST) raised $16 million in an IPO on Friday, September 25th 2020. The company issued 3,100,000 shares at a price of $4.50-$5.50 per share. Laidlaw & Company (UK) Ltd. acted as the underwriter for the IPO and The Benchmark Company was co-manager. How do I buy shares of Amesite? Shares of AMST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AMST) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that...Porter & Company | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amesite Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amesite With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.